Page last updated: 2024-10-30

edaravone and Cerebrovascular Moyamoya Disease

edaravone has been researched along with Cerebrovascular Moyamoya Disease in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Seventeen pediatric patients with cerebral ischemia were administered edaravone at a dose based on body weight from the standard dose given to adults."3.81Efficacy, safety, and outcomes in 17 pediatric cases treated with the free radical scavenger edaravone. ( Aihara, Y; Kawamata, T; Nakamoto, H; Okada, Y; Yamaguchi, K, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakamoto, H1
Aihara, Y1
Yamaguchi, K1
Kawamata, T1
Okada, Y1
Uchino, H1
Nakayama, N1
Kazumata, K1
Kuroda, S1
Houkin, K1

Trials

1 trial available for edaravone and Cerebrovascular Moyamoya Disease

ArticleYear
Edaravone Reduces Hyperperfusion-Related Neurological Deficits in Adult Moyamoya Disease: Historical Control Study.
    Stroke, 2016, Volume: 47, Issue:7

    Topics: Adult; Aged; Anastomosis, Surgical; Antipyrine; Cerebral Revascularization; Cerebrovascular Circulat

2016

Other Studies

1 other study available for edaravone and Cerebrovascular Moyamoya Disease

ArticleYear
Efficacy, safety, and outcomes in 17 pediatric cases treated with the free radical scavenger edaravone.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2015, Volume: 31, Issue:9

    Topics: Adolescent; Antipyrine; Brain Ischemia; Child; Child, Preschool; Edaravone; Female; Free Radical Sca

2015